BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2016
View Archived Issues
FDA grants tazemetostat orphan drug designation for the treatment of rhabdoid tumors
Read More
ONL-1204 granted orphan drug designation in U.S. for retinal detachment
Read More
RedHill Biopharma gives update on Bekinda studies
Read More
Otsuka Pharmaceutical reports pipeline developments of fourth quarter 2015
Read More
Renova Therapeutics and Lonza enter manufacturing agreement for RT-100
Read More
FDA names epacadostat an orphan drug for stage IIB-IV melanoma
Read More
Placental-derived stem cells for the treatment for erectile dysfunction
Read More
MGB Biopharma and UoS sign an agreement to develop novel anti-infective agents
Read More
OPKO Health acquires interest in Xenetic Biosciences
Read More
Promising results reported in nanotechonolgy applied to molecurlay targeted cancer therapy
Read More
Sunshine Lake Pharma patents CDK4 and/or CDK6 inhibitors
Read More
ValiRx advances clinical trial of VAL-201
Read More
Roche divulges TaR-1 ligands
Read More
Gilead Sciences discloses antiviral agents
Read More
Siena Biotech and Roche report BACE1 inhibitors
Read More
Phase III study of Aranesp in MDS meets primary endpoint
Read More
Scientists from Scripps Research Institute win grant to advance Huntington's disease research
Read More
FDA issues complete response letter for Zetia and Vytorin
Read More
Pharnext advances pleotherapy-based treatments for rare diseases
Read More
Sanofi K.K. announces merger with Genzyme Japan
Read More
Shionogi joins Cambridge Therapeutics Consortium
Read More
European approval for Portrazza for advanced squamous NSCLC
Read More
CXCR4 antagonist obtains FDA orphan drug designation for glioblastoma multiforme
Read More
Intramuscular administration of obiltoxaximab well tolerated in healthy adults
Read More
GtreeBNT acquires rights to glioblastoma treatment OKN-007 from OMRF
Read More
Newly developed EGF-targeting peptides block EGF-EGFR interaction
Read More
AstraZeneca establishes new collaborations in CKD
Read More